Characterization of herpes simplex virus type 1 thyraidine kinase mutants selected under a single round of high-dose brivudin

被引:37
作者
Andrei, G [1 ]
Balzarini, J [1 ]
Fiten, P [1 ]
De Clercq, E [1 ]
Opdenakker, G [1 ]
Snoeck, R [1 ]
机构
[1] Katholieke Univ Leuven, Rega Inst Med Res, Virol Lab, B-3000 Louvain, Belgium
关键词
D O I
10.1128/JVI.79.9.5863-5869.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A broad variety of herpes simplex virus type 1 clones was selected under a single round of high-dose selection with brivudin. Mutations in the thymidine kinase (TK) genes consisted of 42% frameshift mutations within homopolymer repeats of G's and C's and single nucleotide substitutions (58%) that produced stop codons (Q261 and R281) or a new codon at the site of the substitution (A168T, R51W, G59W, G206R, R220H, Y239S, and T287 M). The A168T change, associated with an altered TK phenotype, proved to be the most commonly selected substitution. For the different mutants, a correlation between phenotype, genotype, and in vivo neurovirulence was observed.
引用
收藏
页码:5863 / 5869
页数:7
相关论文
共 48 条
  • [1] Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene
    Andrei, G
    Snoeck, R
    De Clercq, E
    Esnouf, R
    Fiten, P
    Opdenakker, G
    [J]. JOURNAL OF GENERAL VIROLOGY, 2000, 81 : 639 - 648
  • [2] Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy
    Bacon, TH
    Levin, MJ
    Leary, JJ
    Sarisky, RT
    Sutton, D
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2003, 16 (01) : 114 - +
  • [3] Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: Risk factors and prognostic significance
    Chakrabarti, S
    Pillay, D
    Ratcliffe, D
    Cane, PA
    Collingham, KE
    Milligan, DW
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (06) : 2055 - 2058
  • [4] Champness JN, 1998, PROTEINS, V32, P350, DOI 10.1002/(SICI)1097-0134(19980815)32:3<350::AID-PROT10>3.0.CO
  • [5] 2-8
  • [6] MMDB: Entrez's 3D-structure database
    Chen, J
    Anderson, JB
    DeWeese-Scott, C
    Fedorova, ND
    Geer, LY
    He, SQ
    Hurwitz, DI
    Jackson, JD
    Jacobs, AR
    Lanczycki, CJ
    Liebert, CA
    Liu, CL
    Madej, T
    Marchler-Bauer, A
    Marchler, GH
    Mazumder, R
    Nikolskaya, AN
    Rao, BS
    Panchenko, AR
    Shoemaker, BA
    Simonyan, V
    Song, JS
    Thiessen, PA
    Vasudevan, S
    Wang, YL
    Yamashita, RA
    Yin, JJ
    Bryant, SH
    [J]. NUCLEIC ACIDS RESEARCH, 2003, 31 (01) : 474 - 477
  • [7] Resistant herpes simplex virus type 1 infection:: An emerging concern after allogeneic stem cell transplantation
    Chen, Y
    Scieux, C
    Garrait, V
    Socié, G
    Rocha, V
    Molina, JM
    Thouvenot, D
    Morfin, F
    Hocqueloux, L
    Garderet, L
    Espérou, H
    Sélimi, F
    Devergie, A
    Leleu, G
    Aymard, M
    Morinet, F
    Gluckman, E
    Ribaud, P
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 31 (04) : 927 - 935
  • [8] Molecular analysis of clinical isolates of acyclovir resistant herpes simplex virus
    Chibo, D
    Druce, J
    Sasadeusz, J
    Birch, C
    [J]. ANTIVIRAL RESEARCH, 2004, 61 (02) : 83 - 91
  • [9] CHRISP CE, 1989, LAB INVEST, V60, P822
  • [10] Survey of resistance of herpes simplex virus to acyclovir in northwest England
    Christophers, J
    Clayton, J
    Craske, J
    Ward, R
    Collins, P
    Trowbridge, M
    Darby, G
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) : 868 - 872